Empower the potential of trastuzumab deruxtecan with novel combinations.
2023-01-01 Rolfo, C; Del Re, M; Russo, A
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer
2017-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Fanizza, Caterina; Scimone, Antonino; Chiofalo, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report.
2020-01-01 Lopes, Ar; Russo, A; Li, Ay; Mccusker, Mg; Kroopnick, Jm; Scilla, K; Mehra, R; Rolfo, C.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
2021-01-01 Cortellini, A; Di Maio, M; Nigro, O; Leonetti, A; Cortinovis, Dl; Aerts, Jg; Guaitoli, G; Barbieri, F; Giusti, R; Ferrara, Mg; Bria, E; D'Argento, E; Grossi, F; Rijavec, E; Guida, A; Berardi, R; Torniai, M; Sforza, V; Genova, C; Mazzoni, F; Garassino, Mc; De Toma, A; Signorelli, D; Gelibter, A; Siringo, M; Marchetti, P; Macerelli, M; Rastelli, F; Chiari, R; Rocco, D; Della Gravara, L; Inno, A; Michele, T; Grassadonia, A; Di Marino, P; Mansueto, G; Zoratto, F; Filetti, M; Santini, D; Citarella, F; Russano, M; Cantini, L; Tuzi, A; Bordi, P; Minuti, G; Landi, L; Ricciardi, S; Migliorino, Mr; Passiglia, F; Bironzo, P; Metro, G; Adamo, V; Russo, A; Spinelli, Gp; Banna, Gl; Friedlaender, A; Addeo, A; Cannita, K; Ficorella, C; Porzio, G; Pinato, Dj.
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era.
2022-01-01 Catania, C; Piperno, G; Russo, A; Greco, C; Agustoni, F; Scotti, V; Proto, C; Sangalli, C; Patani, F; Santacaterina, A; Di Pietro Paolo, M; Agresti, B; Filippi, Ar; Ramella, S.
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
2021-01-01 Rolfo, C; Drilon, A; Hong, D; Mccoach, C; Dowlati, A; Lin, Jj; Russo, A; Schram, Am; Liu, Sv; Nieva, Jj; Nguyen, T; Eshaghian, S; Morse, M; Gettinger, S; Mobayed, M; Goldberg, S; Araujo-Mino, E; Vidula, N; Bardia, A; Subramanian, J; Sashital, D; Stinchcombe, T; Kiedrowski, L; Price, K; Gandara, Dr
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going
2017-01-01 Russo, Alessandro; Franchina, T.; Ricciardi, G. R. R.; Smiroldo, V.; Picciotto, M.; Zanghì, M.; Rolfo, C.; Adamo, V.
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
2020-01-01 Zhang, L; Zheng, J; Ahmed, R; Huang, G; Reid, J; Mandal, R; Maksymuik, A; Sitar, Ds; Tappia, Ps; Ramjiawan, B; Joubert, P; Russo, A; Rolfo, Cd; Wishart, Ds.
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer
2023-01-01 de Miguel-Perez, D; Russo, A; Gunasekaran, M; Buemi, F; Hester, L; Fan, X; Carter-Cooper, Ba; Lapidus, Rg; Peleg, A; Arroyo-Hernández, M; Cardona, Af; Naing, A; Hirsch, Fr; Mack, Pc; Kaushal, S; Serrano, Mj; Adamo, V; Arrieta, O; Rolfo, C.
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy
2018-01-01 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Toscano, G.; Schifano, S.; Lo Certo, G.; Battaglia, A.; Panto', E.; Scaffidi Fonti, M.; Adamo, V.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
2021-01-01 Buti, S; Bersanelli, M; Perrone, F; Bracarda, S; Di Maio, M; Giusti, R; Nigro, O; Cortinovis, Dl; Aerts, Jgjv; Guaitoli, G; Barbieri, F; Ferrara, Mg; Bria, E; Grossi, F; Bareggi, C; Berardi, R; Torniai, M; Cantini, L; Sforza, V; Genova, C; Chiari, R; Rocco, D; Della Gravara, L; Gori, S; De Tursi, M; Di Marino, P; Mansueto, G; Zoratto, F; Filetti, M; Citarella, F; Russano, M; Mazzoni, F; Garassino, Mc; De Toma, A; Signorelli, D; Gelibter, A; Siringo, M; Follador, A; Bisonni, R; Tuzi, A; Minuti, G; Landi, L; Ricciardi, S; Migliorino, Mr; Tabbò, F; Olmetto, E; Metro, G; Adamo, V; Russo, A; Spinelli, Gp; Banna, Gl; Addeo, A; Friedlaender, A; Cannita, K; Porzio, G; Ficorella, C; Carmisciano, L; Pinato, Dj; Mazzaschi, G; Tiseo, M; Cortellini, A.
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
2018-01-01 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site
2016-01-01 Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria; Liguori, Giuseppina; Herberg, Astrid; Normanno, Nicola; Adamo, Vincenzo
Overcoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategies
2020-01-01 Russo, A; Cardona, Af; Caglevic, C; Manca, P; Ruiz-Patiño, A; Arrieta, O; Rolfo, C.
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior.
2022-01-01 Rodriguez-Martinez, A; Simon-Saez, I; Perales, S; Garrido-Navas, C; Russo, A; de Miguel-Perez, D; Puche-Sanz, I; Alaminos, C; Ceron, J; Lorente, Ja; Molina, Mp; Gonzalez, C; Cristofanilli, M; Ortigosa-Palomo, A; Real, Pj; Rolfo, C; Serrano, Mj.
Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin America.
2020-01-01 Ruiz-Patiño, A; Arrieta, O; Pino, Le; Rolfo, C; Ricaurte, L; Recondo, G; Zatarain-Barron, Zl; Corrales, L; Martín, C; Barrón, F; Vargas, C; Carranza, H; Otero, J; Rodriguez, J; Sotelo, C; Viola, L; Russo, A; Rosell, R; Cardona, Af.
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
2024-01-01 Longo, V; Della Corte, Cm; Russo, A; Spinnato, F; Ambrosio, F; Ronga, R; Marchese, A; Del Giudice, T; Sergi, C; Casaluce, F; Gilli, M; Montrone, M; Gristina, V; Sforza, V; Reale, Ml; Di Liello, R; Servetto, A; Lipari, H; Longhitano, C; Vizzini, L; Manzo, A; Cristofano, A; Paolelli, L; Nardone, A; De Summa, S; Perrone, A; Bisceglia, C; Derosa, C; Nardone, V; Viscardi, G; Galetta, D And Vitiello F
Moving Forward Liquid Biopsy in Early Liver Cancer Detection
2023-01-01 Rolfo, C; Russo, A
The Evolving Role of Liquid Biopsy in Lung Cancer.
2022-01-01 Malapelle, U; Pisapia, P; Pepe, F; Russo, G; Buono, M; Russo, A; Gomez, J; Khorshid, O; Mack, Pc; Rolfo, C; Troncone, G
Prognostic and predictive clinical factors in patients affected by Non-Small-Cell Lung Cancer receiving Nivolumab.
2020-01-01 Pantano, F; Russano, M; Berruti, A; Mansueto, G; Migliorino, Mr; Adamo, V; Aprile, G; Gelibter, A; Ficorella, C; Falcone, A; Russo, A; Aieta, M; Maio, M; Martelli, O; Barni, S; Napolitano, A; Roca, E; Quadrini, S; Iacono, D; Russo, A; Calvetti, L; Occhipinti, Ma; Cortellini, A; Vasile, E; Passiglia, F; Imperatori, M; Calabrò, L; Di Giacomo, Am; Petrelli, F; Pasquini, G; Franchina, T; Venditti, O; Intagliata, S; Galvano, A; Vincenzi, B; Tonini, G; Santini, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Empower the potential of trastuzumab deruxtecan with novel combinations. | 1-gen-2023 | Rolfo, C; Del Re, M; Russo, A | |
| Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer | 1-gen-2017 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Fanizza, Caterina; Scimone, Antonino; Chiofalo, Giuseppe; Giordano, Antonio; Adamo, Vincenzo | |
| Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report. | 1-gen-2020 | Lopes, Ar; Russo, A; Li, Ay; Mccusker, Mg; Kroopnick, Jm; Scilla, K; Mehra, R; Rolfo, C. | |
| Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy | 1-gen-2021 | Cortellini, A; Di Maio, M; Nigro, O; Leonetti, A; Cortinovis, Dl; Aerts, Jg; Guaitoli, G; Barbieri, F; Giusti, R; Ferrara, Mg; Bria, E; D'Argento, E; Grossi, F; Rijavec, E; Guida, A; Berardi, R; Torniai, M; Sforza, V; Genova, C; Mazzoni, F; Garassino, Mc; De Toma, A; Signorelli, D; Gelibter, A; Siringo, M; Marchetti, P; Macerelli, M; Rastelli, F; Chiari, R; Rocco, D; Della Gravara, L; Inno, A; Michele, T; Grassadonia, A; Di Marino, P; Mansueto, G; Zoratto, F; Filetti, M; Santini, D; Citarella, F; Russano, M; Cantini, L; Tuzi, A; Bordi, P; Minuti, G; Landi, L; Ricciardi, S; Migliorino, Mr; Passiglia, F; Bironzo, P; Metro, G; Adamo, V; Russo, A; Spinelli, Gp; Banna, Gl; Friedlaender, A; Addeo, A; Cannita, K; Ficorella, C; Porzio, G; Pinato, Dj. | |
| Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era. | 1-gen-2022 | Catania, C; Piperno, G; Russo, A; Greco, C; Agustoni, F; Scotti, V; Proto, C; Sangalli, C; Patani, F; Santacaterina, A; Di Pietro Paolo, M; Agresti, B; Filippi, Ar; Ramella, S. | |
| NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types | 1-gen-2021 | Rolfo, C; Drilon, A; Hong, D; Mccoach, C; Dowlati, A; Lin, Jj; Russo, A; Schram, Am; Liu, Sv; Nieva, Jj; Nguyen, T; Eshaghian, S; Morse, M; Gettinger, S; Mobayed, M; Goldberg, S; Araujo-Mino, E; Vidula, N; Bardia, A; Subramanian, J; Sashital, D; Stinchcombe, T; Kiedrowski, L; Price, K; Gandara, Dr | |
| Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going | 1-gen-2017 | Russo, Alessandro; Franchina, T.; Ricciardi, G. R. R.; Smiroldo, V.; Picciotto, M.; Zanghì, M.; Rolfo, C.; Adamo, V. | |
| A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection | 1-gen-2020 | Zhang, L; Zheng, J; Ahmed, R; Huang, G; Reid, J; Mandal, R; Maksymuik, A; Sitar, Ds; Tappia, Ps; Ramjiawan, B; Joubert, P; Russo, A; Rolfo, Cd; Wishart, Ds. | |
| Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer | 1-gen-2023 | de Miguel-Perez, D; Russo, A; Gunasekaran, M; Buemi, F; Hester, L; Fan, X; Carter-Cooper, Ba; Lapidus, Rg; Peleg, A; Arroyo-Hernández, M; Cardona, Af; Naing, A; Hirsch, Fr; Mack, Pc; Kaushal, S; Serrano, Mj; Adamo, V; Arrieta, O; Rolfo, C. | |
| The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy | 1-gen-2018 | Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Toscano, G.; Schifano, S.; Lo Certo, G.; Battaglia, A.; Panto', E.; Scaffidi Fonti, M.; Adamo, V. | |
| Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. | 1-gen-2021 | Buti, S; Bersanelli, M; Perrone, F; Bracarda, S; Di Maio, M; Giusti, R; Nigro, O; Cortinovis, Dl; Aerts, Jgjv; Guaitoli, G; Barbieri, F; Ferrara, Mg; Bria, E; Grossi, F; Bareggi, C; Berardi, R; Torniai, M; Cantini, L; Sforza, V; Genova, C; Chiari, R; Rocco, D; Della Gravara, L; Gori, S; De Tursi, M; Di Marino, P; Mansueto, G; Zoratto, F; Filetti, M; Citarella, F; Russano, M; Mazzoni, F; Garassino, Mc; De Toma, A; Signorelli, D; Gelibter, A; Siringo, M; Follador, A; Bisonni, R; Tuzi, A; Minuti, G; Landi, L; Ricciardi, S; Migliorino, Mr; Tabbò, F; Olmetto, E; Metro, G; Adamo, V; Russo, A; Spinelli, Gp; Banna, Gl; Addeo, A; Friedlaender, A; Cannita, K; Porzio, G; Ficorella, C; Carmisciano, L; Pinato, Dj; Mazzaschi, G; Tiseo, M; Cortellini, A. | |
| Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel | 1-gen-2018 | Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V. | |
| Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site | 1-gen-2016 | Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria; Liguori, Giuseppina; Herberg, Astrid; Normanno, Nicola; Adamo, Vincenzo | |
| Overcoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategies | 1-gen-2020 | Russo, A; Cardona, Af; Caglevic, C; Manca, P; Ruiz-Patiño, A; Arrieta, O; Rolfo, C. | |
| Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior. | 1-gen-2022 | Rodriguez-Martinez, A; Simon-Saez, I; Perales, S; Garrido-Navas, C; Russo, A; de Miguel-Perez, D; Puche-Sanz, I; Alaminos, C; Ceron, J; Lorente, Ja; Molina, Mp; Gonzalez, C; Cristofanilli, M; Ortigosa-Palomo, A; Real, Pj; Rolfo, C; Serrano, Mj. | |
| Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin America. | 1-gen-2020 | Ruiz-Patiño, A; Arrieta, O; Pino, Le; Rolfo, C; Ricaurte, L; Recondo, G; Zatarain-Barron, Zl; Corrales, L; Martín, C; Barrón, F; Vargas, C; Carranza, H; Otero, J; Rodriguez, J; Sotelo, C; Viola, L; Russo, A; Rosell, R; Cardona, Af. | |
| Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy. | 1-gen-2024 | Longo, V; Della Corte, Cm; Russo, A; Spinnato, F; Ambrosio, F; Ronga, R; Marchese, A; Del Giudice, T; Sergi, C; Casaluce, F; Gilli, M; Montrone, M; Gristina, V; Sforza, V; Reale, Ml; Di Liello, R; Servetto, A; Lipari, H; Longhitano, C; Vizzini, L; Manzo, A; Cristofano, A; Paolelli, L; Nardone, A; De Summa, S; Perrone, A; Bisceglia, C; Derosa, C; Nardone, V; Viscardi, G; Galetta, D And Vitiello F | |
| Moving Forward Liquid Biopsy in Early Liver Cancer Detection | 1-gen-2023 | Rolfo, C; Russo, A | |
| The Evolving Role of Liquid Biopsy in Lung Cancer. | 1-gen-2022 | Malapelle, U; Pisapia, P; Pepe, F; Russo, G; Buono, M; Russo, A; Gomez, J; Khorshid, O; Mack, Pc; Rolfo, C; Troncone, G | |
| Prognostic and predictive clinical factors in patients affected by Non-Small-Cell Lung Cancer receiving Nivolumab. | 1-gen-2020 | Pantano, F; Russano, M; Berruti, A; Mansueto, G; Migliorino, Mr; Adamo, V; Aprile, G; Gelibter, A; Ficorella, C; Falcone, A; Russo, A; Aieta, M; Maio, M; Martelli, O; Barni, S; Napolitano, A; Roca, E; Quadrini, S; Iacono, D; Russo, A; Calvetti, L; Occhipinti, Ma; Cortellini, A; Vasile, E; Passiglia, F; Imperatori, M; Calabrò, L; Di Giacomo, Am; Petrelli, F; Pasquini, G; Franchina, T; Venditti, O; Intagliata, S; Galvano, A; Vincenzi, B; Tonini, G; Santini, D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26843
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269047
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24590
- reserved1362
- open891